Sign In
Buy SWAV
$334.75
+0 (+0%)
At Close: Aug 29, 2024
Why ShockWave Medical Dipped Today
04:26pm, Tuesday, 14'th Jun 2022
The Fed's meeting has investors incredibly antsy about stocks with high valuations.
Earnings Estimates Rising for Shockwave Medical (SWAV): Will It Gain?
01:32pm, Thursday, 09'th Jun 2022
Shockwave Medical (SWAV) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Why Shares of ShockWave Medical Jumped 13.5% on Monday
05:14pm, Monday, 06'th Jun 2022
More index funds are likely to be buying the medical equipment stock in the future.
Shockwave Medical's (SWAV) IVL Cleared for Use in China
12:48pm, Tuesday, 24'th May 2022
Shockwave Medical's (SWAV) latest regulatory approval is expected to serve a wider patient pool.
ShockWave Medical: The Next Edwards
12:59pm, Wednesday, 11'th May 2022
The release of Shockwave C² is a similar event to TAVRs for Edwards Lifesciences. Considering the cardiovascular industry tailwinds, the unique niche in calcified stenosis, and safety profile should
Shockwave Medical (SWAV) Beats on Q1 Earnings & Revenues
08:17am, Wednesday, 11'th May 2022
Shockwave Medical's (SWAV) first-quarter results reflect robust revenue growth and expansion in gross margin.
ShockWave Medical, Inc. (SWAV) CEO Doug Godshall on Q1 2022 Results - Earnings Call Transcript
10:53pm, Monday, 09'th May 2022
ShockWave Medical, Inc. (NASDAQ:SWAV ) Q1 2022 Earnings Conference Call May 9, 2022 4:30 PM ET Company Participants Debbie Kaster – Vice President-Investor Relations Doug Godshall – President and
Shockwave Medical (SWAV) Surpasses Q1 Earnings and Revenue Estimates
06:48pm, Monday, 09'th May 2022
Shockwave Medical (SWAV) delivered earnings and revenue surprises of 105.26% and 5.74%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Shockwave Medical Stock Soars On Q1 Earnings Beat, Raised FY22 Guidance
05:34pm, Monday, 09'th May 2022
Shockwave Medical Inc (NASDAQ: SWAV) reported first-quarter revenue of $93.63 million, an increase of 193.5% year-over-year, beating the consensus of $86.41 million. The gross margin for Q1 expanded
2 Medtech Stocks You Can Buy and Hold for the Next Decade
10:53am, Friday, 15'th Apr 2022
These two companies are leading the charge for improved patient outcomes.
Shockwave Medical's (SWAV) New Launch to Lower IVL Treatment Time
12:03pm, Tuesday, 05'th Apr 2022
Shockwave Medical's (SWAV) latest global commercial launch is expected to serve a more diverse patient pool.
Shockwave Medical Announces Japanese Regulatory Approval of Coronary IVL
12:30pm, Wednesday, 30'th Mar 2022 GlobeNewswire Inc.
Transformative Shockwave C2 Intravascular Lithotripsy Catheter Will Soon Be Available in One of the World’s Largest Coronary Intervention Markets
Here's Why You Should Retain ShockWave Medical (SWAV) Stock
03:32pm, Tuesday, 22'nd Mar 2022 Zacks Investment Research
ShockWave Medical (SWAV) continues to benefit from solid R&D efforts and commitment toward clinical studies. However, limited commercial expertise is a woe.
Here's Why You Should Retain ShockWave Medical (SWAV) Stock
12:47pm, Tuesday, 22'nd Mar 2022
ShockWave Medical (SWAV) continues to benefit from solid R&D efforts and commitment toward clinical studies. However, limited commercial expertise is a woe.
Shockwave Medical (SWAV) is a Top-Ranked Momentum Stock: Should You Buy?
02:00pm, Thursday, 17'th Mar 2022 Zacks Investment Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
